Parasitic worm genomes: largest-ever dataset released

New resource boosts research into worms that infect millions

Parasitic worm genomes: largest-ever dataset released

141128-wormbase.jpg
WormBase-ParaSite helps researchers to identify genetic similarities in different helminth species that share certain traits

The largest collection of helminth genomic data ever assembled has been published in the new, open-access WormBase-ParaSite. Developed jointly by EMBL-EBI and the Wellcome Trust Sanger Institute, this new resource will be a major asset in the fight against parasitic worms, which infect more than one billion people worldwide.

Roundworms, whipworms, hookworms and other helminths produce a disease burden that exceeds that of malaria or tuberculosis. The Helminth Genome Initiative, which has provided much of the data for the WormBase-ParaSite, is a global community of researchers dedicated to reducing this disease burden by identifying weaknesses in the worms' genetic code.

"Helminth researchers are caught in a catch-22 situation where, because there is a lack of resources, it's difficult to secure research funding, which means progress can be slow. There's a danger that this situation will cause a terminal decline in the field; a pretty dangerous scenario when many of these worms cause diseases that affect millions. Our hope is that this community resource will help to turn the situation around."

Dr Matt Berriman, leader of the Helminth Genomics Initiative at the Sanger Institute and joint Principal Investigator for the WormBase-ParaSite project

The public database, which is funded by the Biotechnology and Biological Sciences Research Council (BBSRC), contains 89 draft genome sequences for a total of 82 helminth species, including 30 published genomes. Of the 59 unpublished genomes, 44 were sequenced at the Sanger Institute as part of the 50 Helminth Genomes project, nine genomes were sequenced at The Genome Institute at Washington University and the remaining six were sequenced by other helminth researchers throughout the world.

WormBase-ParaSite combines these data to help researchers identify genetic similarities in different helminth species that share certain traits, such as the ability to invade through human skin. This approach will speed up the difficult, costly search for candidate genes.

"In all, the genomes in WormBase-ParaSite contain about 1.5 million genes, and we have used cutting-edge software from the Ensembl project to organise these genes into family trees. These trees show, in high-definition, how the genes are related to each other and how they have evolved. This will allow researchers to study the genetic basis for important similarities and differences between parasitic worms on an unprecedented scale."

Dr Kevin Howe, project leader for WormBase-ParaSite at EMBL-EBI

Currently, many of the genomes in WormBase-ParaSite are early drafts and, accordingly, highly fragmented. Contributions from the helminth research community will gradually fill these gaps as data emerges from new research, building a robust resource for future investigation.

"In human biology, we take things like access to large genomic data sets for granted. This just hasn't been available for helminth research before now. This capacity-building project will catapult the field into a new era of comparative work, boosting funding and research in this crucial area."

Dr Paul Kersey, Team Leader at EMBL-EBI and joint Principal Investigator for WormBase-ParaSite

Notes to Editors
Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
Hinxton,
Cambridgeshire,
CB10 1SA,
UK

Mobile +44 (0) 7900 607793

Recent News

Low doses of radiation promote cancer-capable cells
New research in mice helps to understand the risks around exposure to low doses of radiation, such as CT scans and x-rays
Chan Zuckerberg Initiative boosts Human Cell Atlas research at the Sanger Institute
Seed Networks projects will focus on specific tissues, such as the thymus, lung, liver, kidney and immune system
Widely-available antibiotics could be used in the treatment of ‘superbug’ MRSA
Genomic analysis shows that a significant number of strains are susceptible to penicillin combined with clavulanic acid